Date | Time | Content |
April 17, 2026 | 14:00-18:00 | Registration |
2026年4月18日 April 18, 2026 | 08:00-08:40 | Registration |
| 09:00-12:00 | Opening Ceremony & Keynote Speeches Host: Prof. Guodong Lu, Fudan University, China | |
09:00-09:20 | Opening Ceremony & Group Photo | |
09:20-12:00 | Keynote Speeches | |
09:20-09:55 | Keynote Speech 1: Wei Chen, Professor, XJTLU Entrepreneur College (Taicang), China; Academician of the National Academy of Inventors Title: New Development on Photodynamic Therapy for Cancer Treatment | |
09:55-10:30 | Keynote Speech 2: Yicheng Ni, LaboHeal Chief Oncology Expert; Professor, Zhongda Hospital Affiliated to Southeast University, China Title: Sequential Dual-Target Broad-Spectrum Diagnosis and Treatment Integration (OncoCiDia): A New Cancer Treatment Model Based on the First Principles of Practice? | |
10:30-10:50 | Tea Break & Poster | |
10:50-11:25 | Keynote Speech 3: Michael Thompson, Professor, University of Toronto, Canada; Fellow of the Royal Society of Canada. Title: Multiplexed biosensor detection of biomarkers for screening of early-stage ovarian cancer | |
11:25-11:40 | Invited Academic Publishing Speech: Liangliang Shen, Content Development Manager, Wiley Life Sciences Journals | |
12:00-14:00 | Lunch & Break | |
2026年4月18日 April 18, 2026 | Session 1: Multi-Omics, Immunology & Translational Innovations in Cancer Session Chair：Prof. Pier Paolo Piccaluga, University of Bologna, Italy | |
14:00-14:30 | Keynote Speech 1: Zhiling Yu, Professor, Hong Kong Baptist University, China Title: Dual Inhibition of EGFR and TLR4-MD2 as a Novel Strategy for Cancer Treatment | |
14:30-15:00 | Keynote Speech 2: Andrew Teschendorff, Professor, Chinese Academy of Sciences, China Title: Towards the development of cancer risk prediction strategies from single-cell omics | |
15:00-15:30 | Keynote Speech 3: Ahmed G. Hegazi, Professor, National Research Center, Egypt | |
15:30-15:40 | Break | |
15:40-16:10 | Keynote Speech 4: Dipayan Rudra, Associate Professor, ShanghaiTech University, China Title: Novel Insights on Regulatory T cell Mediated Tumor Immune Tolerance | |
16:10-16:40 | Keynote Speech 5: Saman Hosseinkhani, Tarbiat Modares University, Iran Title: MiRGD@NTA@Au-Fe3O4 nanoparticles: a platform for circulating tumor cells (CTCs) isolation and detection | |
16:40-16:55 | Oral Presentation 1: Yunhong Tian, Professor, Affiliated Hospital of North Sichuan Medical College, China | |
16:55-17:10 | Oral Presentation 2: Xinran Liu, Doctoral Student, Peking University, China | |
17:10-18:00 | More Oral Presentations | |
Closing | ||
2026年4月18日 April 18, 2026 | Session 2: Tumor Microenvironment & the New Wave of Targeted/Immunotherapies Session Chair：Dr. Haibo Wang, Hangzhou Institute of Medicine Chinese Academy of Sciences | |
14:00-14:30 | Keynote Speech 1: Kai Zhang, Associate Researcher, Shanghai Cancer Institute, China | |
14:30-15:00 | Keynote Speech 2: Christopher L. Antos, Associate Professor, ShanghaiTech University, China Title: How An Electrophysiological Signal is Biologically Integrated to Scale Appendages During Regeneration and Development | |
15:00-15:30 | Keynote Speech 3: Hua Su, Researcher, Fudan University, China Title：Collagen Cleavage Signaling Dictates Pancreatic Cancer Development | |
15:30-15:40 | Break | |
15:40-16:10 | Keynote Speech 4: Feng He, Researcher, Shanghai University of Traditional Chinese Medicine, China Title: The Role of Stress Response Protein ATF4 in Liver Injury, Regeneration, and Hepatocarcinogenesis | |
16:10-16:25 | Oral Presentation 1: Jiayan Yan, Zhongshan Hospital, Fudan University, China | |
16:25-16:40 | Oral Presentation 2: Meng Cui, Lecture, Inner Mongolia Medical University, China | |
16:40-16:55 | Oral Presentation 3: Xiao Li, Shanghai University of Traditional Chinese Medicine, China | |
16:55-18:00 | More Oral Presentations | |
Closing | ||
Note: The conference schedule may still be subject to adjustment.